Weiss Multi-Strategy Advisers’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-56,882
Closed -$5.6M 610
2023
Q3
$5.6M Buy
56,882
+9,282
+20% +$963K 0.13% 207
2023
Q2
$5.04M Sell
47,600
-96,605
-67% -$10.3M 0.1% 289
2023
Q1
$14.7M Buy
144,205
+71,000
+97% +$7.08M 0.34% 84
2022
Q4
$7.17M Buy
73,205
+23,205
+46% +$2.14M 0.2% 161
2022
Q3
$4.03M Sell
50,000
-8,057
-14% -$707K 0.11% 279
2022
Q2
$5.12M Buy
+58,057
New +$5.2M 0.15% 209
2021
Q4
Sell
-47,568
Closed -$4.23M 713
2021
Q3
$4.23M Buy
+47,568
New +$4.19M 0.09% 283
2021
Q1
Sell
-40,000
Closed -$3.15M 759
2020
Q4
$3.15M Buy
+40,000
New +$3.08M 0.06% 341
2020
Q1
Sell
-48,000
Closed -$4.46M 521
2019
Q4
$4.46M Buy
+48,000
New +$4.03M 0.07% 326
2014
Q3
Sell
-3,860
Closed -$290K 632
2014
Q2
$290K Sell
3,860
-3,690
-49% -$268K 0.01% 657
2014
Q1
$514K Buy
+7,550
New +$495K 0.01% 650
2013
Q4
Sell
-6,800
Closed -$450K 1040
2013
Q3
$450K Sell
6,800
-2,361
-26% -$154K 0.01% 547
2013
Q2
$601K Buy
+9,161
New +$644K 0.02% 450

Other funds holding INGR

Weiss Multi-Strategy Advisers's INGR Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Ingredion (INGR) in Q4 2023, closing a stake of 56,882 shares — an estimated $5.6M sold.

Weiss Multi-Strategy Advisers first reported a position in INGR in Q2 2013 and held it in 13 quarters. The position peaked at $14.7M in Q1 2023. 519 funds tracked by Wall St. Rank hold INGR as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Ingredion position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 56,882 Ingredion shares in Q4 2023, an estimated $5.6M.
  • Weiss Multi-Strategy Advisers first reported a position in Ingredion in Q2 2013 and held it in 13 quarters.
  • Weiss Multi-Strategy Advisers's Ingredion position peaked at $14.7M in Q1 2023.
  • 519 funds tracked by Wall St. Rank held Ingredion as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.